• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sirtuin2 增强了小鼠肝癌模型中肝脏自然杀伤细胞的肿瘤杀伤功能。

Sirtuin2 enhances the tumoricidal function of liver natural killer cells in a mouse hepatocellular carcinoma model.

机构信息

Department of Blood Transfusion, Zhongnan Hospital of Wuhan University, Wuhan, China.

Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Cancer Immunol Immunother. 2019 Jun;68(6):961-971. doi: 10.1007/s00262-019-02337-5. Epub 2019 Apr 6.

DOI:10.1007/s00262-019-02337-5
PMID:30955067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11028107/
Abstract

Hepatocellular carcinoma (HCC) is the third most lethal cancer in the world. Natural killer (NK) cell-mediated immunity is crucial for tumor surveillance and therapy. Characterization of the regulatory mechanisms of NK cell function is important for developing novel immunotherapies against HCC. In this study, we used a chemical-induced mouse HCC model to identify the upregulation of Sirtuin2 (SIRT2) in liver NK cells. In particular, SIRT2 was predominantly expressed in liver CD94 NK cells. The HCC liver microenvironment induced SIRT2 expression in NK cells. In addition, overexpression of exogenous SIRT2 significantly upregulated the production of cytokines and cytotoxic mediators in activated NK cells. Consistently, SIRT2-overexpressing NK cells showed a stronger tumoricidal effect on hepatoma cells. Moreover, SIRT2 remarkably promoted the phosphorylation of Extracellular-signal-regulated kinase 1/2 (Erk1/2) and p38 Mitogen-activated protein kinases (MAPK) in activated NK cells. SIRT2 knockdown in liver CD94 NK cells impaired their cytotoxic effect on hepatoma cells. Our study indicates that SIRT2 enhances the tumoricidal activity of liver NK cells in HCC.

摘要

肝细胞癌 (HCC) 是全球第三大致命癌症。自然杀伤 (NK) 细胞介导的免疫对于肿瘤监测和治疗至关重要。NK 细胞功能的调控机制的特征对于开发针对 HCC 的新型免疫疗法很重要。在这项研究中,我们使用化学诱导的小鼠 HCC 模型来鉴定肝 NK 细胞中 Sirtuin2 (SIRT2) 的上调。特别是,SIRT2 在肝 CD94 NK 细胞中表达丰富。HCC 肝微环境诱导 NK 细胞中 SIRT2 的表达。此外,外源性 SIRT2 的过表达显著上调了活化 NK 细胞中细胞因子和细胞毒性介质的产生。一致地,SIRT2 过表达的 NK 细胞对肝癌细胞表现出更强的杀伤作用。此外,SIRT2 显著促进了活化 NK 细胞中细胞外信号调节激酶 1/2 (Erk1/2) 和丝裂原活化蛋白激酶 (MAPK) 的磷酸化。肝 CD94 NK 细胞中的 SIRT2 敲低削弱了它们对肝癌细胞的细胞毒性作用。我们的研究表明,SIRT2 增强了 HCC 中肝 NK 细胞的杀伤活性。

相似文献

1
Sirtuin2 enhances the tumoricidal function of liver natural killer cells in a mouse hepatocellular carcinoma model.Sirtuin2 增强了小鼠肝癌模型中肝脏自然杀伤细胞的肿瘤杀伤功能。
Cancer Immunol Immunother. 2019 Jun;68(6):961-971. doi: 10.1007/s00262-019-02337-5. Epub 2019 Apr 6.
2
Taste receptor T1R1/T1R3 promotes the tumoricidal activity of hepatic CD49a CD49b natural killer cells.味觉受体 T1R1/T1R3 促进肝 CD49a CD49b 自然杀伤细胞的杀瘤活性。
Eur J Immunol. 2018 Dec;48(12):2031-2041. doi: 10.1002/eji.201847688. Epub 2018 Oct 10.
3
Kbtbd2 inhibits the cytotoxic activity of immortalized NK cells through down-regulating mTOR signaling in a mouse hepatocellular carcinoma model.Kbtbd2 通过下调 mTOR 信号抑制永生化 NK 细胞在小鼠肝癌模型中的细胞毒性活性。
Eur J Immunol. 2018 Apr;48(4):683-695. doi: 10.1002/eji.201747281. Epub 2018 Jan 29.
4
Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.颗粒蛋白前体使肝癌细胞对自然杀伤细胞的细胞毒性具有抗性。
Cancer Immunol Res. 2014 Dec;2(12):1209-19. doi: 10.1158/2326-6066.CIR-14-0096. Epub 2014 Oct 14.
5
hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.人白细胞介素-15基因修饰的人自然杀伤细胞(NKL-IL15)增强体内抗人肝癌效应。
Immunobiology. 2014 Jul;219(7):547-53. doi: 10.1016/j.imbio.2014.03.007. Epub 2014 Mar 20.
6
MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3.微小RNA-506通过靶向信号转导和转录激活因子3促进自然杀伤细胞对人肝癌细胞的细胞毒性。
Yonsei Med J. 2019 Jan;60(1):22-29. doi: 10.3349/ymj.2019.60.1.22.
7
Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.转输表达肿瘤坏死因子相关凋亡诱导配体的自然杀伤细胞可预防部分肝切除术后肝细胞癌的复发。
Transplantation. 2006 Dec 27;82(12):1712-9. doi: 10.1097/01.tp.0000250935.41034.2d.
8
Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma.扩展和激活的自然杀伤细胞用于肝细胞癌的免疫治疗。
Cancer Immunol Res. 2016 Jul;4(7):574-81. doi: 10.1158/2326-6066.CIR-15-0229. Epub 2016 May 13.
9
Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression.靶向雄激素受体(AR)→白细胞介素12A信号可增强索拉非尼联合自然杀伤细胞免疫疗法的疗效,从而更好地抑制肝癌进展。
Mol Cancer Ther. 2016 Apr;15(4):731-742. doi: 10.1158/1535-7163.MCT-15-0706. Epub 2016 Mar 3.
10
NLRP3 Deficiency in Hepatocellular Carcinoma Enhances Surveillance of NK-92 through a Modulation of MICA/B.NLRP3 缺失增强了 NK-92 对肝癌的监测作用,通过调节 MICA/B 实现。
Int J Mol Sci. 2021 Aug 27;22(17):9285. doi: 10.3390/ijms22179285.

引用本文的文献

1
Research progress of SIRTs activator resveratrol and its derivatives in autoimmune diseases.SIRTs 激活剂白藜芦醇及其衍生物在自身免疫性疾病中的研究进展。
Front Immunol. 2024 Jun 19;15:1390907. doi: 10.3389/fimmu.2024.1390907. eCollection 2024.
2
Resident Immune Cells of the Liver in the Tumor Microenvironment.肿瘤微环境中肝脏的常驻免疫细胞
Front Oncol. 2022 Jul 19;12:931995. doi: 10.3389/fonc.2022.931995. eCollection 2022.
3
SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters.SIRT2通过靶向转录因子p53来增加HBV增强子和启动子的活性,从而促进HBV转录和复制。
Front Microbiol. 2022 May 19;13:836446. doi: 10.3389/fmicb.2022.836446. eCollection 2022.
4
Nuclear Sirtuins and the Aging of the Immune System.核 Sirtuins 与免疫系统衰老。
Genes (Basel). 2021 Nov 23;12(12):1856. doi: 10.3390/genes12121856.
5
Sirtuins at the Service of Healthy Longevity.服务于健康长寿的去乙酰化酶
Front Physiol. 2021 Nov 25;12:724506. doi: 10.3389/fphys.2021.724506. eCollection 2021.
6
Acetylation in Tumor Immune Evasion Regulation.肿瘤免疫逃逸调控中的乙酰化作用。
Front Pharmacol. 2021 Nov 22;12:771588. doi: 10.3389/fphar.2021.771588. eCollection 2021.
7
Application of Immunotherapy in Hepatocellular Carcinoma.免疫疗法在肝细胞癌中的应用。
Front Oncol. 2021 Aug 26;11:699060. doi: 10.3389/fonc.2021.699060. eCollection 2021.
8
Identification of proteins associated with development of psoriatic arthritis in peripheral blood mononuclear cells: a quantitative iTRAQ-based proteomics study.鉴定与外周血单个核细胞银屑病关节炎发病相关的蛋白:基于 iTRAQ 的定量蛋白质组学研究。
J Transl Med. 2021 Aug 3;19(1):331. doi: 10.1186/s12967-021-03006-x.
9
SIRT2 promotes murine melanoma progression through natural killer cell inhibition.SIRT2 通过抑制自然杀伤细胞促进小鼠黑色素瘤的进展。
Sci Rep. 2021 Jun 21;11(1):12988. doi: 10.1038/s41598-021-92445-z.
10
SUMOylation is essential for Sirt2 tumor-suppressor function in neuroblastoma.SUMOylation 对于 Sirt2 肿瘤抑制因子在神经母细胞瘤中的功能至关重要。
Neoplasia. 2021 Jan;23(1):129-139. doi: 10.1016/j.neo.2020.11.013. Epub 2020 Dec 11.

本文引用的文献

1
SIRT2 Inhibition Confers Neuroprotection by Downregulation of FOXO3a and MAPK Signaling Pathways in Ischemic Stroke.SIRT2 抑制通过下调缺血性中风中的 FOXO3a 和 MAPK 信号通路发挥神经保护作用。
Mol Neurobiol. 2018 Dec;55(12):9188-9203. doi: 10.1007/s12035-018-1058-0. Epub 2018 Apr 14.
2
Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering.用于癌症免疫疗法的下一代自然杀伤细胞:基因工程的承诺。
Curr Opin Immunol. 2018 Apr;51:146-153. doi: 10.1016/j.coi.2018.03.013. Epub 2018 Mar 30.
3
The immunology of hepatocellular carcinoma.肝细胞癌的免疫学。
Nat Immunol. 2018 Mar;19(3):222-232. doi: 10.1038/s41590-018-0044-z. Epub 2018 Jan 29.
4
Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma.开发针对 GPC3 的嵌合抗原受体工程化自然杀伤细胞用于治疗肝细胞癌。
Mol Ther. 2018 Feb 7;26(2):366-378. doi: 10.1016/j.ymthe.2017.12.012. Epub 2017 Dec 19.
5
Kbtbd2 inhibits the cytotoxic activity of immortalized NK cells through down-regulating mTOR signaling in a mouse hepatocellular carcinoma model.Kbtbd2 通过下调 mTOR 信号抑制永生化 NK 细胞在小鼠肝癌模型中的细胞毒性活性。
Eur J Immunol. 2018 Apr;48(4):683-695. doi: 10.1002/eji.201747281. Epub 2018 Jan 29.
6
An Unbiased Linkage Approach Reveals That the p53 Pathway Is Coupled to NK Cell Maturation.一种无偏连锁分析方法揭示p53通路与自然杀伤细胞成熟相关联。
J Immunol. 2017 Aug 15;199(4):1490-1504. doi: 10.4049/jimmunol.1600789. Epub 2017 Jul 14.
7
Engineering Natural Killer Cells for Cancer Immunotherapy.用于癌症免疫治疗的工程化自然杀伤细胞
Mol Ther. 2017 Aug 2;25(8):1769-1781. doi: 10.1016/j.ymthe.2017.06.012. Epub 2017 Jun 28.
8
Targeting NK-cell checkpoints for cancer immunotherapy.针对自然杀伤细胞检查点的癌症免疫疗法。
Curr Opin Immunol. 2017 Apr;45:73-81. doi: 10.1016/j.coi.2017.01.003. Epub 2017 Feb 23.
9
Who watches the watchmen? Regulation of the expression and activity of sirtuins.谁来监管监管者?沉默调节蛋白的表达与活性调控
FASEB J. 2016 Dec;30(12):3942-3960. doi: 10.1096/fj.201600410RR. Epub 2016 Sep 2.
10
Liver-infiltrating CD11bCD27 NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression.肝浸润的 CD11bCD27 NK 亚群导致肝癌患者 NK 细胞功能障碍,并与肿瘤进展相关。
Cell Mol Immunol. 2017 Oct;14(10):819-829. doi: 10.1038/cmi.2016.28. Epub 2016 Jun 20.